Longevity Tech Fund

Longevity Tech Fund is a venture firm focused on advancing the science and infrastructure of human healthspan. It invests in breakthrough technologies targeting fundamental aging mechanisms, across therapeutics, platforms, data and AI, and prevention. Its investment strategy employs rigorous scientific diligence, leveraging in-house PhDs and an expert network to identify and support early-stage companies.

The fund was established in 2019 by Managing Partner Petr Sramek and his partners. Their foundational belief posits that extending healthy human lifespan is both a scientific possibility and an ethical imperative. This conviction propels their mission to foster a future where technological progress leads to longer, healthier, and more productive lives.

Longevity Tech Fund engages investors seeking healthspan opportunities and backs startups developing innovative longevity technologies. Its vision is to transform societal perceptions of aging, moving beyond individual health outcomes. The firm strives to establish sustainable healthcare and unlock human potential across extended lifespans, creating widespread, lasting impact.